Continuous glucose monitors (CGMs) are monitoring devices people with diabetes use. They apply them directly to the skin and ...

Abbott (NYSE:ABT) reached an agreement with Dexcom (Nasdaq:DXCM) to settle all outstanding patent disputes between companies.

The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious, class I type due to the risk for ...

CGMs have saved my life after a heart attack four years ago. I recently tried the Dexcom Stelo OTC CGM, and it's been mighty ...

FreeStyle Libre is a continuous glucose monitoring (CGM) system that allows a person to check their blood sugar in real time without having to prick their finger. The system has two components ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

A panelist discusses how continuous glucose monitoring (CGM) technology can help overcome therapeutic inertia and key barriers to glycemic control in type 2 diabetes (T2D) patients by providing ...

MISSISSAUGA, ON , Dec. 17, 2024 /CNW/ -- Abbott (NYSE: ABT) today announced that the Government of Alberta has added Abbott's FreeStyle Libre 2 * flash glucose monitoring system to the Alberta Drug ...